Mannching Sherry Ku,Chih-Kuang Chen,Wei-Shu Lu,Chih-Ming Chen,I-Yin Lin
申请号：
US13553271
公开号：
US20130022610A1
申请日:
2012.07.19
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Methods for treating abnormal glycosylated hemoglobin (HbA1c) levels in a patient in need thereof, wherein the provided methods comprise administering to a patient in need a therapeutically effective amount of an Interleukin-1β modulator. Also, the invention provides compositions comprising at least one lipid modifying agent and an IL-1β modulator.
